Abbisko Therapeutics' Series A Round

Abbisko Therapeutics raised a round of funding on February 06, 2017.

Abbisko Therapeutics (和誉生物) focuses on innovative small molecule immunomodulators for cancers prevalent in Asia, using a combination of in-house R&D and outside CROs.…

Articles about Abbisko Therapeutics' Series A Round: